Since insulin resistance and decreased Glut-4 levels in adipocyte tissue are characteristic, the development of insulin-sensitizing agents against T2DM is an important current research topic [26, 48]. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.